Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults - Scorecard - MDSpire

Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults

  • By

  • Cheng-Chun Yang

  • Chung-Lieh Hung

  • Chen-Yen Chien

  • Yang-Wen Hsieh

  • Wei-Ming Huang

  • Chun-Ho Yun

  • Ricardo C. Cury

  • May 28, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Intrathoracic Visceral Fat Deposits via Quantitative CT and Their Link to New-Onset Heart Failure in Asymptomatic Individuals

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAsymptomatic adults undergoing cardiac CT for health screening.
Care Setting

Key Highlights

  • 140 participants developed HF, predominantly HFpEF, during a median follow-up of 10.3 years.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Increased risk of HF associated with higher volumes of EAT and PARF.
        • Consider assessing other cardiovascular risk factors in conjunction with VAT.

        Patient & Prescribing Data

        Clinical Best Practices

        • follow_up_intervals

        Related Resources & Content

        Original Source(s)

        Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults

        • by Cheng-Chun Yang, Chung-Lieh Hung, Chen-Yen Chien, Yang-Wen Hsieh, Wei-Ming Huang, Chun-Ho Yun, Ricardo C. Cury

        • May 28, 2026

        Related Content

        Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis

        Complete revascularization and heart failure risk in acute coronary syndrome across the ejection fraction spectrum: focus on LVEF-dependent effects

        Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention